An examination of the immunology of cancer patients.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 783052)

Published in Int J Cancer on September 15, 1976

Authors

A J Cochran, R M Mackie, R M Grant, C E Ross, M D Connell, G Sandilands, K Whaley, D E Hoyle, A M Jackson

Articles citing this

Remote metastases from intracranial tumours. J Clin Pathol (1978) 0.83

Articles by these authors

Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg (1992) 9.97

Modulation of the alternative complement pathways by beta 1 H globulin. J Exp Med (1976) 7.00

A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science (2000) 5.52

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. N Engl J Med (2001) 5.33

A novel DNA repair response is induced in human cells exposed to ionizing radiation at the G1/S-phase border. Radiat Res (1996) 4.99

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med (1998) 3.81

Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med (2001) 3.69

Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56

Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J Exp Med (1980) 3.50

Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology (1985) 2.89

Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator. Science (1976) 2.70

The classification of malignant melanoma and its histologic reporting. Cancer (1973) 2.67

Age and depression. J Health Soc Behav (1992) 2.66

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med (1989) 2.56

High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest (1998) 2.47

Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? Sex Transm Infect (2006) 2.45

Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol (1995) 2.44

Clinical, immunologic, and serologic findings in men at risk for acquired immunodeficiency syndrome. The San Francisco Men's Health Study. JAMA (1987) 2.43

BCG immunotherapy of bladder cancer: 20 years on. Lancet (1999) 2.38

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection. J Infect Dis (2000) 2.36

Measurement of joint inflammation. A radioisotopic method. Ann Rheum Dis (1970) 2.35

Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection. J Virol (1999) 2.29

Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med (1995) 2.26

Dividing work, sharing work, and in-between: marriage patterns and depression. Am Sociol Rev (1983) 2.22

Have sperm counts been reduced 50 percent in 50 years? A statistical model revisited. Fertil Steril (1995) 2.14

Impaired replication of protease inhibitor-resistant HIV-1 in human thymus. Nat Med (2001) 2.13

Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome. J Infect Dis (1999) 2.12

Sjogren's syndrome. I. Sicca components. Q J Med (1973) 2.08

The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma. Br J Dermatol (2004) 2.07

Sjögren's syndrome and autoimmunity in a geriatric population. Age Ageing (1972) 2.01

Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet (1970) 2.00

Control or defense? Depression and the sense of control over good and bad outcomes. J Health Soc Behav (1990) 1.97

Systemic complement activation in psoriasis vulgaris. Clin Exp Dermatol (1996) 1.94

Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. J Virol (1998) 1.94

Tanning with ultraviolet A sunbeds. BMJ (1990) 1.93

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy. AIDS (1999) 1.86

Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease. Br Med J (1972) 1.84

A statistical aid to the diagnosis of keratoconjunctivitis sicca. Q J Med (1972) 1.81

Explaining the social patterns of depression: control and problem solving--or support and talking? J Health Soc Behav (1989) 1.79

Sjogren's syndrome. 2. Clinical associations and immunological phenomena. Q J Med (1973) 1.77

Components of depressed mood in married men and women. The Center for Epidemiologic Studies' Depression Scale. Am J Epidemiol (1984) 1.73

Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation (1996) 1.70

Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol (1976) 1.69

Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis (1975) 1.66

Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases. Arch Dermatol (1998) 1.60

The articular scan in patients with rheumatoid arthritis: a possible method of quantitating joint inflammation using radio-technetium. Clin Sci (1968) 1.60

Derivation of knee joint synovial perfusion. Using the Xenon (133Xe) clearance technique. Ann Rheum Dis (1970) 1.59

Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy. J Neurovirol (2009) 1.57

Systemic lupus erythematosus complicating hyper IgE syndrome. Br J Rheumatol (1997) 1.55

Cyclical micromovement and fracture healing. J Bone Joint Surg Br (1995) 1.54

Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. Hum Pathol (1991) 1.54

Socially-desirable response and acquiescence in a cross-cultural survey of mental health. J Health Soc Behav (1984) 1.54

Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load. J Infect Dis (2000) 1.54

Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. J Infect Dis (1996) 1.53

Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques. Hum Pathol (1989) 1.52

A review of the histology, ultrastructure, immunohistology, and molecular biology of extra-adrenal paragangliomas. Arch Pathol Lab Med (1989) 1.51

Juvenile plantar dermatosis: a new entity?. Clin Exp Dermatol (1976) 1.51

Impact of the ovulatory cycle on virologic and immunologic markers in HIV-infected women. J Infect Dis (2000) 1.51

Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection. AIDS (1999) 1.50

A cohort mortality study of two California refinery and petrochemical plants. J Occup Med (1993) 1.45

Intra-articular steroids after arthroscopy for osteoarthritis of the knee. J Bone Joint Surg Br (1999) 1.43

Immunological responses in Sjogren's syndrome and rheumatoid arthritis. Clin Exp Immunol (1971) 1.41

Malignant melanoma. A REVIEW OF ') YEARS' experience in Glasgow, Scotland. Cancer (1969) 1.40

Assessment of an anti-T-cell receptor variable region antibody panel in cutaneous T-cell lymphoma. Br J Dermatol (1994) 1.39

Central spinal stenosis due to pseudogout: a case report. J Bone Joint Surg Br (1994) 1.39

Effect of Glyvenol (CIBA) on pain and on capillary resistance in rheumatoid arthritis. Ann Rheum Dis (1969) 1.39

Arteriovenous fistula: a complication following renal biopsy of suspected bilateral Wilms' tumor. Med Pediatr Oncol (1997) 1.38

Complement-mediated inhibition of immune precipitation in patients with immune complex diseases. Clin Exp Immunol (1983) 1.38

Diagnostic immunopathology. West J Med (1986) 1.38

C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase. J Clin Invest (1976) 1.38

The suitability of SunCheck patches and Tanscan cards for monitoring the sunburning effectiveness of sunlight. Br J Dermatol (1993) 1.38

Modulation of C2 biosynthesis by antigen-antibody complexes. J Clin Lab Immunol (1982) 1.38

Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils. J Immunol (1997) 1.37

Detection of S-100 protein as an aid to the identification of melanocytic tumors. Int J Cancer (1982) 1.37

Health and the ozone layer. BMJ (1988) 1.37

Returning to the doctor: the effect of client characteristics, type of practice, and experiences with care. J Health Soc Behav (1982) 1.36

UVA-induced melanocytic lesions. Br J Dermatol (1987) 1.35

Cytokine production in culture by cells isolated from the synovial membrane. J Autoimmun (1989) 1.33

T cells expressing gamma delta chain receptors in rheumatoid arthritis. J Autoimmun (1988) 1.32

Infectivity of the human immunodeficiency virus: estimates from a prospective study of homosexual men. J Infect Dis (1987) 1.31

Quality of outpatient pediatric care: the influence of physicians' background, socialization, and work/information environment on performance. J Health Soc Behav (1978) 1.31

Cryptosporidiosis in HIV-seropositive patients. Q J Med (1993) 1.30

Age and the effect of economic hardship on depression. J Health Soc Behav (2001) 1.30

Occult melanoma in lymph nodes detected by antiserum to S-100 protein. Int J Cancer (1984) 1.29

Golf science research at the beginning of the twenty-first century. J Sports Sci (2003) 1.29

Hardship and depression. J Health Soc Behav (1985) 1.28

Complement metabolism in the seronegative arthritides. Ann Rheum Dis (1974) 1.28

A muscle contusion injury model. Biomechanics, physiology, and histology. Am J Sports Med (1995) 1.27

Minority status, ethnic culture, and distress: a comparison of Blacks, Whites, Mexicans, and Mexican Americans. AJS (1980) 1.27

Clinical studies on inflammation in human knee joints: xenon (133Xe) clearances correlated with clinical assessment in various arthritides and studies on the effect of intra-articularly administered hydrocortisone in rheumatoid arthritis. Clin Sci (1970) 1.27

Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and skynovial membrane cells from patients with rheumatoid arthritis. Immunology (1980) 1.26

Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst (1993) 1.23

The prevalence of haemoglobinopathies, nutritional iron and folate deficiencies in native and immigrant children in Glasgow. Health Bull (Edinb) (1978) 1.23

The long-term results of conservative management of severely displaced fractures of the calcaneus. J Bone Joint Surg Br (1984) 1.22

Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure. AIDS (1998) 1.21

Melanoma from unknown primary site and amelanotic melanoma. Semin Oncol (1982) 1.20

Effects of histamine on monocyte complement production. I. Inhibition of C2 production mediated by its action on H2 receptors. Clin Exp Immunol (1980) 1.19

Lymphocytes with T and B cell properties in a lymphoproliferative disorder. Lancet (1974) 1.18

Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patients. AIDS (2000) 1.18